CClinicalTrials.gg
TerminatedNCT07770581Updated Sep 18, 2026

Determining if the Buzzy® Personal Pain Relief Device Reduces Injection Pain of Propofol as Much as Intravenous Lidocaine in Children

An interventional study of Buzzy device and Intravenous lidocaine in Propofol Injection Pain in Children, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago. Terminated at 1 site in United States. Open to participants aged 12 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-09-18.

Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago · Not applicable, Interventional, and Prevention

Why this study was terminated
PI left institution and study activity was not continued (enrollment not complete)
Phase
Not applicable
Study type
Interventional
Enrollment
49
Allocation
Randomized
Ages
12 Years to 17 Years
Sex
All
01

Study summary

Propofol is a drug commonly used for induction of general anesthesia in children as well as adults; however, propofol can cause pain on injection, possibly more frequently in children. One common method of preventing propofol injection pain is the injection of lidocaine just prior to the injection of propofol through an intravenous catheter. This practice is sometimes, but not universally, effective, and involves exposure of patients to an additional drug. Our proposal is to use a non-pharmacologic adjunct in an attempt to attenuate the pain of propofol injection. The Buzzy® personal pain relief device is an FDA-approved product that provides non-pharmacologic relief of pain from minor painful procedures in children. The investigators propose the non-invasive Buzzy® personal pain relief device might prove just as effective at relieving the pain of propofol injection as the injection of intravenous lidocaine just prior to propofol injection. Randomized groups and a blinded observer will be used in this study of 106 children, with one group of patients receiving a current standard of care for reduction of the pain of propofol injection, that is, lidocaine prior to propofol, and one group receiving the placement of the Buzzy® device above the injection site prior to injection of propofol to reduce the pain of propofol injection.

02

Conditions studied

  • Propofol Injection Pain in Children

Keywords

  • propofol
  • Buzzy device
  • propofol injection pain
03

Who can participate

Ages eligible
12 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients who are in the American Society of Anesthesiologists with physical status classification I to III (meaning healthy patients, patients with mild systemic disease, and patients with serious controlled systemic disease)
  • Between the ages of 12 and 17
  • Presenting from home for procedures including, but not limited to, upper and lower endoscopy, orthopedic surgery, and medical imaging.

Exclusion criteria

Exclusion Criteria:

  • Patients requiring a rapid sequence induction of anesthesia and patients requiring an emergency procedure
  • Patients requiring mask induction for anesthesia
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
49 participants (actual)

Study arms

  • Experimental
    Buzzy device

    Use of the Buzzy device during propofol induction in an attempt to alleviate propofol injection pain

    Device: Buzzy device

  • Active comparator
    Intravenous lidocaine

    Use of intravenous lidocaine during propofol induction in an attempt to alleviate propofol injection pain

    Drug: Intravenous lidocaine

Interventions

  • DeviceBuzzy device

    Also known as: Buzzy personal pain relief device

  • DrugIntravenous lidocaine
05

What researchers measure

Primary outcomes

  1. Non-inferiority of Buzzy pain relief device as compared to intravenous lidocaine at preventing pain on injection of propofol

    Two scales will be used by the observer to rate the amount of pain, if any, on propofol injection, the FLACC (face, legs, activity, cry, consolability) Scale and the Cameron Four Point Scale for Pain on Propofol Injection. The FLACC Scale is a 0-10 scale where the observer rates pain based on facial expression, movement of the body and legs, vocalization, and reassurability. The Cameron Scale was developed by researchers to specifically rate the pain of propofol injection for a previous study, and uses the presence or absence of grimace, cry, and withdrawal to rate pain on a 0-3 scale. Both scales are being used because the FLACC Scale was not specifically designed for propofol pain, and has some limitations in its application for this purpose; however, the Cameron Scale is limited by its narrow application of three types of expressions of pain.

    Time frame: Every minute starting 1 minute prior to induction of anesthesia, during induction, and after induction of anesthesia for a total of ten minutes

Secondary outcomes

  1. Vital Signs

    The heart rate and blood pressure will be recorded just prior to induction of anesthesia, when 25% of the induction dose of propofol has been given, and every minute after induction of anesthesia for eight minutes. Heart rate and blood pressure variations will serve as a secondary indicator of pain on propofol injection.

    Time frame: Every minute starting 1 minute prior to induction of anesthesia, during induction, and after induction of anesthesia for a total of ten minutes

06

Study locations

1 site
  • Ann & Robert H. Lurie Children's Hospital of Chicago
    Chicago, Illinois 60611, United States
07

Registry details

Key details

Study ID
NCT07770581
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Responsible party
Sponsor
First posted
Aug 18, 2026
Start date
Jun 2014
Primary completion
Jun 30, 2017
Completion
Jun 30, 2017
Last update
Sep 18, 2026

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion